Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|99|2|222-228

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.99, Iss.2, 2017-01, pp. : 222-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

By  

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

STAMPEDE‐ing towards androgen biosynthesis inhibition for treatment of high‐risk hormone‐naïve prostate cancer: changing the LATITUDE

By  

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 9-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2535-2545

John Wiley & Sons Inc

Access to resources Recommend Favorite

The transcriptional programme of the androgen receptor (AR) in prostate cancer

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 358-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prescription Practice for LH-RH Analogs and Androgen Receptor Antagonists in the Treatment of Advanced Prostate Cancer in Germany (1993–2003)

By  

Urologia Internationalis, Vol. 77, Iss. 4, 2006-11 ,pp. : 311-316

Karger

Access to resources Recommend Favorite